Tetra Bio-Pharma (OTC: TBPMF) Accelerates REBORN1© Trial
Ethics Committee approves REBORN1© protocol amendment allowing for the addition of two immediate release oral opioids to be compared against QIXLEEF™. REBORN1© is the first of its kind proof-of-concept phase 2 study comparing a cannabinoid-based […]